SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-15-009081
Filing Date
2015-11-24
Accepted
2015-11-24 17:19:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO SCHEDULE 13D sc13d1115a2woodford_north.htm SC 13D/A 67923
2 GRAPHIC img01.jpg GRAPHIC 10838
3 GRAPHIC img02.jpg GRAPHIC 24013
4 GRAPHIC img03.jpg GRAPHIC 2252
  Complete submission text file 0001213900-15-009081.txt   120904
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Subject) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-62381 | Film No.: 151253550
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 00 44 1865809023
Woodford Investment Management LLP (Filed by) CIK: 0001634557 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A